Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Benefits and Harms of Cranial Electrical Stimulation.

Shekelle PG, Cook IA, Mak S.

Ann Intern Med. 2018 Aug 21;169(4):269-270. doi: 10.7326/L18-0293. No abstract available.

PMID:
30128522
2.

Dr McClintock and Colleagues Reply.

McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, Krystal A, Sampson S, Morales O, Nelson BG, George MS, Lisanby SH.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 17lr11851a. doi: 10.4088/JCP.17lr11851a. No abstract available.

3.

Benefits and Harms of Cranial Electrical Stimulation for Chronic Painful Conditions, Depression, Anxiety, and Insomnia: A Systematic Review.

Shekelle PG, Cook IA, Miake-Lye IM, Booth MS, Beroes JM, Mak S.

Ann Intern Med. 2018 Mar 20;168(6):414-421. doi: 10.7326/M17-1970. Epub 2018 Feb 13.

PMID:
29435567
4.

The Future of Psychiatry Commission.

Eyre HA, Vahabzadeh A, Abbott R, Cook IA, Berk M.

Lancet Psychiatry. 2018 Jan;5(1):13. doi: 10.1016/S2215-0366(17)30410-8. No abstract available.

PMID:
29277199
5.

Change in Quantitative EEG Theta Cordance as a Potential Predictor of Repetitive Transcranial Magnetic Stimulation Clinical Outcome in Major Depressive Disorder.

Hunter AM, Nghiem TX, Cook IA, Krantz DE, Minzenberg MJ, Leuchter AF.

Clin EEG Neurosci. 2018 Sep;49(5):306-315. doi: 10.1177/1550059417746212. Epub 2017 Dec 10.

PMID:
29224411
6.

Consensus Recommendations for the Clinical Application of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Depression.

McClintock SM, Reti IM, Carpenter LL, McDonald WM, Dubin M, Taylor SF, Cook IA, O'Reardon J, Husain MM, Wall C, Krystal AD, Sampson SM, Morales O, Nelson BG, Latoussakis V, George MS, Lisanby SH; National Network of Depression Centers rTMS Task Group; American Psychiatric Association Council on Research Task Force on Novel Biomarkers and Treatments.

J Clin Psychiatry. 2018 Jan/Feb;79(1). pii: 16cs10905. doi: 10.4088/JCP.16cs10905.

PMID:
28541649
7.

Quantitative Electroencephalographic Biomarkers in Preclinical and Human Studies of Huntington's Disease: Are They Fit-for-Purpose for Treatment Development?

Leuchter MK, Donzis EJ, Cepeda C, Hunter AM, Estrada-Sánchez AM, Cook IA, Levine MS, Leuchter AF.

Front Neurol. 2017 Mar 30;8:91. doi: 10.3389/fneur.2017.00091. eCollection 2017. Review.

8.

Can neurophysiologic measures serve as biomarkers for the efficacy of repetitive transcranial magnetic stimulation treatment of major depressive disorder?

Kobayashi B, Cook IA, Hunter AM, Minzenberg MJ, Krantz DE, Leuchter AF.

Int Rev Psychiatry. 2017 Apr;29(2):98-114. doi: 10.1080/09540261.2017.1297697. Epub 2017 Mar 31. Review.

PMID:
28362541
9.

Escitalopram but not placebo modulates brain rhythmic oscillatory activity in the first week of treatment of Major Depressive Disorder.

Leuchter AF, Hunter AM, Jain FA, Tartter M, Crump C, Cook IA.

J Psychiatr Res. 2017 Jan;84:174-183. doi: 10.1016/j.jpsychires.2016.10.002. Epub 2016 Oct 7.

PMID:
27770740
10.

Transcranial Magnetic Stimulation for Obsessive-Compulsive Disorder: An Updated Systematic Review and Meta-analysis.

Trevizol AP, Shiozawa P, Cook IA, Sato IA, Kaku CB, Guimarães FB, Sachdev P, Sarkhel S, Cordeiro Q.

J ECT. 2016 Dec;32(4):262-266. Review.

PMID:
27327557
11.

Trigeminal nerve stimulation (TNS) for posttraumatic stress disorder and major depressive disorder: An open-label proof-of-concept trial.

Trevizol AP, Sato IA, Cook IA, Shiozawa P, Lowenthal R, Cordeiro Q.

Epilepsy Behav. 2016 Jul;60:240-241. doi: 10.1016/j.yebeh.2016.04.014. Epub 2016 May 10. No abstract available.

PMID:
27177991
12.

Neurophysiologic Correlates of Headache Pain in Subjects With Major Depressive Disorder.

Scanlon GC, Jain FA, Hunter AM, Cook IA, Leuchter AF.

Clin EEG Neurosci. 2017 May;48(3):159-167. doi: 10.1177/1550059416632411. Epub 2016 Mar 21.

PMID:
27000108
13.

Trigeminal Nerve Stimulation for Comorbid Posttraumatic Stress Disorder and Major Depressive Disorder.

Cook IA, Abrams M, Leuchter AF.

Neuromodulation. 2016 Apr;19(3):299-305. doi: 10.1111/ner.12399. Epub 2016 Jan 28.

PMID:
26818103
14.

Trigeminal Nerve Stimulation (TNS) for Major Depressive Disorder in the Elderly: An Open Label Proof-of-Concept Trial.

Trevizol AP, Shiozawa P, Cook IA, Sato IA, Dos Santos Guimarães FB, Diniz BS, Lowenthal R, Barros MD, Cordeiro Q.

Brain Stimul. 2016 Jan-Feb;9(1):146-7. doi: 10.1016/j.brs.2015.10.002. Epub 2015 Dec 11. No abstract available.

PMID:
26710678
15.

Authors' reply.

Leuchter AF, Hunter AM, Tartter M, Cook IA.

Br J Psychiatry. 2015 Dec;207(6):561-2. doi: 10.1192/bjp.207.6.561b. No abstract available.

PMID:
26628700
16.

Trigeminal Nerve Stimulation (TNS) for Panic Disorder: An Open Label Proof-of-Concept Trial.

Trevizol AP, Sato IA, Cook IA, Lowenthal R, Barros MD, Cordeiro Q, Shiozawa P.

Brain Stimul. 2016 Jan-Feb;9(1):161-2. doi: 10.1016/j.brs.2015.10.010. Epub 2015 Oct 30. No abstract available.

PMID:
26603963
17.

Trigeminal Nerve Stimulation (TNS) for the Treatment of Irritable Bowel Syndrome in an Elderly Patient with Major Depressive Disorder: A Case Study.

Trevizol AP, Cordeiro Q, Cook IA, Barros MD, Shiozawa P.

Brain Stimul. 2015 Nov-Dec;8(6):1235-6. doi: 10.1016/j.brs.2015.09.001. Epub 2015 Sep 7. No abstract available.

PMID:
26433608
18.

Antidepressant treatment history and drug-placebo separation in a placebo-controlled trial in major depressive disorder.

Hunter AM, Cook IA, Tartter M, Sharma SK, Disse GD, Leuchter AF.

Psychopharmacology (Berl). 2015 Oct;232(20):3833-40. doi: 10.1007/s00213-015-4047-2. Epub 2015 Aug 29.

PMID:
26319158
19.

Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression.

Leuchter AF, Cook IA, Feifel D, Goethe JW, Husain M, Carpenter LL, Thase ME, Krystal AD, Philip NS, Bhati MT, Burke WJ, Howland RH, Sheline YI, Aaronson ST, Iosifescu DV, O'Reardon JP, Gilmer WS, Jain R, Burgoyne KS, Phillips B, Manberg PJ, Massaro J, Hunter AM, Lisanby SH, George MS.

Brain Stimul. 2015 Jul-Aug;8(4):787-94. doi: 10.1016/j.brs.2015.05.005. Epub 2015 May 22.

PMID:
26143022
20.

Author's reply: To PMID 25213159.

Leuchter AF, Hunter AM, Tartter M, Cook IA.

Br J Psychiatry. 2015 May;206(5):435. doi: 10.1192/bjp.206.5.435. No abstract available.

PMID:
25934309
21.

Everyday Mishaps and Lapses in Ethics, Professionalism, and Self-Care: A Faculty Development Workshop.

Bursch B, Piacentini J, Cook IA, Stuber ML.

Acad Psychiatry. 2016 Feb;40(1):97-9. doi: 10.1007/s40596-015-0319-8. Epub 2015 Apr 21. No abstract available.

22.

The potential use of trigeminal nerve stimulation in the treatment of epilepsy.

Cook IA, Kealey CP, DeGiorgio CM.

Ther Deliv. 2015 Mar;6(3):273-5. doi: 10.4155/tde.14.120. No abstract available.

23.

Rhythms and blues: modulation of oscillatory synchrony and the mechanism of action of antidepressant treatments.

Leuchter AF, Hunter AM, Krantz DE, Cook IA.

Ann N Y Acad Sci. 2015 May;1344:78-91. doi: 10.1111/nyas.12742. Epub 2015 Mar 23. Review.

24.

Trigeminal Nerve Stimulation (TNS) for Post-traumatic Stress Disorder: A Case Study.

Trevizol AP, Shiozawa P, Albuquerque Sato I, da Silva ME, de Barros Calfat EL, Alberto RL, Cook IA, Cordeiro Q.

Brain Stimul. 2015 May-Jun;8(3):676-8. doi: 10.1016/j.brs.2015.02.008. Epub 2015 Feb 26. No abstract available.

PMID:
25795622
25.

Intermediate phenotypes and biomarkers of treatment outcome in major depressive disorder.

Leuchter AF, Hunter AM, Krantz DE, Cook IA.

Dialogues Clin Neurosci. 2014 Dec;16(4):525-37. Review.

26.

Trigeminal Nerve Stimulation (TNS) for Generalized Anxiety Disorder: A Case Study.

Trevizol AP, Shiozawa P, Sato IA, Calfat EL, Alberto RL, Cook IA, Medeiros HH, Cordeiro Q.

Brain Stimul. 2015 May-Jun;8(3):659-60. doi: 10.1016/j.brs.2014.12.009. Epub 2014 Dec 31. No abstract available.

PMID:
25650095
27.

An eight-week, open-trial, pilot feasibility study of trigeminal nerve stimulation in youth with attention-deficit/hyperactivity disorder.

McGough JJ, Loo SK, Sturm A, Cowen J, Leuchter AF, Cook IA.

Brain Stimul. 2015 Mar-Apr;8(2):299-304. doi: 10.1016/j.brs.2014.11.013. Epub 2014 Nov 28.

PMID:
25533244
28.

A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.

Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA.

J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977.

29.

The Antidepressant Treatment Response Index as a Predictor of Reboxetine Treatment Outcome in Major Depressive Disorder.

Caudill MM, Hunter AM, Cook IA, Leuchter AF.

Clin EEG Neurosci. 2015 Oct;46(4):277-84. doi: 10.1177/1550059414532443. Epub 2014 Sep 24.

30.

Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression.

Leuchter AF, Hunter AM, Tartter M, Cook IA.

Br J Psychiatry. 2014 Dec;205(6):443-9. doi: 10.1192/bjp.bp.113.140343. Epub 2014 Sep 11.

31.

Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study.

Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF.

Psychooncology. 2014 Jun;23(6):713-5. doi: 10.1002/pon.3487. Epub 2014 Feb 6. No abstract available.

32.

Heart rate variability and treatment outcome in major depression: a pilot study.

Jain FA, Cook IA, Leuchter AF, Hunter AM, Davydov DM, Ottaviani C, Tartter M, Crump C, Shapiro D.

Int J Psychophysiol. 2014 Aug;93(2):204-10. doi: 10.1016/j.ijpsycho.2014.04.006. Epub 2014 Apr 24.

33.

Neurophysiologic predictors of response to atomoxetine in young adults with attention deficit hyperactivity disorder: a pilot project.

Leuchter AF, McGough JJ, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM, Cook IA.

J Psychiatr Res. 2014 Jul;54:11-8. doi: 10.1016/j.jpsychires.2014.03.009. Epub 2014 Mar 27.

PMID:
24726639
34.

Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?

Cook IA, Hunter AM, Korb AS, Leuchter AF.

J Psychiatr Res. 2014 Jun;53:69-75. doi: 10.1016/j.jpsychires.2014.01.018. Epub 2014 Feb 11.

PMID:
24630467
35.

Neuromodulation for depression: invasive and noninvasive (deep brain stimulation, transcranial magnetic stimulation, trigeminal nerve stimulation).

Cook IA, Espinoza R, Leuchter AF.

Neurosurg Clin N Am. 2014 Jan;25(1):103-16. doi: 10.1016/j.nec.2013.10.002. Review.

PMID:
24262903
36.

Neurophysiologic effects of repeated exposure to antidepressant medication: are brain functional changes during antidepressant administration influenced by learning processes?

Hunter AM, Cook IA, Abrams M, Leuchter AF.

Med Hypotheses. 2013 Dec;81(6):1004-11. doi: 10.1016/j.mehy.2013.09.016. Epub 2013 Sep 17.

37.

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.

Janicak PG, Dunner DL, Aaronson ST, Carpenter LL, Boyadjis TA, Brock DG, Cook IA, Lanocha K, Solvason HB, Bonneh-Barkay D, Demitrack MA.

CNS Spectr. 2013 Dec;18(6):322-32. doi: 10.1017/S1092852913000357. Epub 2013 Jul 30.

PMID:
23895940
38.

Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study.

Cook IA, Schrader LM, Degiorgio CM, Miller PR, Maremont ER, Leuchter AF.

Epilepsy Behav. 2013 Aug;28(2):221-6. doi: 10.1016/j.yebeh.2013.05.008. Epub 2013 Jun 14.

PMID:
23773978
39.

A genome-wide association study of a sustained pattern of antidepressant response.

Hunter AM, Leuchter AF, Power RA, Muthén B, McGrath PJ, Lewis CM, Cook IA, Garriock HA, McGuffin P, Uher R, Hamilton SP.

J Psychiatr Res. 2013 Sep;47(9):1157-65. doi: 10.1016/j.jpsychires.2013.05.002. Epub 2013 May 30.

40.

Rostral anterior cingulate activity in major depressive disorder: state or trait marker of responsiveness to medication?

Hunter AM, Korb AS, Cook IA, Leuchter AF.

J Neuropsychiatry Clin Neurosci. 2013 Spring;25(2):126-33. doi: 10.1176/appi.neuropsych.11110330.

PMID:
23686030
41.

The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.

Leuchter AF, Cook IA, Jin Y, Phillips B.

Front Hum Neurosci. 2013 Feb 26;7:37. doi: 10.3389/fnhum.2013.00037. eCollection 2013.

42.

Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.

Cook IA, Hunter AM, Gilmer WS, Iosifescu DV, Zisook S, Burgoyne KS, Howland RH, Trivedi MH, Jain R, Greenwald S, Leuchter AF.

J Clin Psychiatry. 2013 Jan;74(1):51-6. doi: 10.4088/JCP.10m06813.

PMID:
23419226
43.

Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy.

DeGiorgio CM, Soss J, Cook IA, Markovic D, Gornbein J, Murray D, Oviedo S, Gordon S, Corralle-Leyva G, Kealey CP, Heck CN.

Neurology. 2013 Feb 26;80(9):786-91. doi: 10.1212/WNL.0b013e318285c11a. Epub 2013 Jan 30.

44.

Relationship between medical student perceptions of mistreatment and mistreatment sensitivity.

Bursch B, Fried JM, Wimmers PF, Cook IA, Baillie S, Zackson H, Stuber ML.

Med Teach. 2013;35(3):e998-1002. doi: 10.3109/0142159X.2012.733455. Epub 2012 Oct 26.

45.

Comment on 'The use of the EEG in measuring therapeutic drug action: focus on depression and antidepressants'.

Leuchter A, Cook IA, Hunter AM.

J Psychopharmacol. 2012 Aug;26(8):1162-3; author reply 1164. doi: 10.1177/0269881111430732. No abstract available.

PMID:
22807041
46.

Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.

Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA.

Depress Anxiety. 2012 Jul;29(7):587-96. doi: 10.1002/da.21969. Epub 2012 Jun 11.

PMID:
22689344
47.

Does prior antidepressant treatment of major depression impact brain function during current treatment?

Hunter AM, Cook IA, Leuchter AF.

Eur Neuropsychopharmacol. 2012 Oct;22(10):711-20. doi: 10.1016/j.euroneuro.2012.02.005. Epub 2012 Mar 23.

PMID:
22445212
48.

Resting-state quantitative electroencephalography reveals increased neurophysiologic connectivity in depression.

Leuchter AF, Cook IA, Hunter AM, Cai C, Horvath S.

PLoS One. 2012;7(2):e32508. doi: 10.1371/journal.pone.0032508. Epub 2012 Feb 24.

49.

Headspace Moisture Mapping and the Information That Can Be Gained about Freeze-Dried Materials and Processes.

Cook IA, Ward KR.

PDA J Pharm Sci Technol. 2011 Sep-Oct;65(5):457-67. doi: 10.5731/pdajpst.2011.00760.

PMID:
22293835
50.

Manipulation of cigarette craving with transcranial magnetic stimulation.

Brody AL, Cook IA.

Biol Psychiatry. 2011 Oct 15;70(8):702-3. doi: 10.1016/j.biopsych.2011.08.001. No abstract available.

Supplemental Content

Support Center